unyango lwe-metastatic olungelulo oluncinci unyango lomhlaza wemiphunga weseli

Unyango lwe-Metastatic Non-Small Cell Lung Cancer Eli nqaku libonelela ngamagqabantshintshi abanzi okhetho lonyango lomhlaza wemiphunga we-metastatic non-umncinci weseli yemiphunga (NSCLC), kubandakanywa ichemotherapy, unyango olujoliswe kuyo, unyango lwe-immunotherapy, kunye nonyango lwemitha. Siphonononga ukuqhubela phambili kwamva nje kunye neengqwalasela zokukhetha esona sicwangciso sonyango esisebenzayo ngokusekwe kwizinto zesigulana ngasinye. Le ngcaciso yenzelwe iinjongo zemfundo kuphela kwaye akufanele ithathwe njengengcebiso yezonyango. Soloko udibana nomboneleli wakho wezempilo ukuze ufumane isikhokelo somntu.

Ukuqonda iMetastatic Non-Small Cell Lung Cancer

Umhlaza wemiphunga weMetastatic ongeyonxalenye encinci (NSCLC) yenzeka xa iiseli zomhlaza eziphuma emiphungeni zisasazeka kwezinye iindawo zomzimba. Le yimeko emandundu efuna indlela yonyango oluxubileyo. Isicwangciso esithile sonyango sixhomekeke kwizinto ezininzi, kuquka uhlobo kunye nenqanaba lomhlaza, impilo yesigulane, kunye nendawo ye-metastases. Ukuxilongwa kwangoko kunye nonyango olufanelekileyo lubalulekile ekuphuculeni iziphumo.

Iinketho zonyango lwe-Metastatic NSCLC

Unyango ngamachiza

I-Chemotherapy lunyango oluqhelekileyo lwe umhlaza wemiphunga wemetastatic ongeyonxalenye encinci, ukusebenzisa iziyobisi ukubulala iiseli zomhlaza. Kukho iirejimeni ezahlukeneyo zechemotherapy, kwaye ukhetho luxhomekeke kwizinto ezahlukeneyo, njengempilo yesigulane kunye nohlobo oluthile lwe-NSCLC. Iziyobisi eziqhelekileyo zechemotherapy ezisetyenziswayo ziquka i-cisplatin, i-carboplatin, i-paclitaxel, kunye ne-docetaxel. Iziphumo ebezingalindelekanga zinokwahluka kodwa zihlala zibandakanya isicaphucaphu, ukudinwa, nokulahleka kweenwele. I Iziko lomhlaza leSizwe ibonelela ngolwazi oluthe kratya kwiirejimeni zechemotherapy kwi-NSCLC.

Unyango ekujoliswe kulo

Unyango ekujoliswe kulo lusebenzisa amachiza ajolise ngokukodwa kwiiseli zomhlaza ezinotshintsho oluthile lwemfuza. Olu nyango lusebenza ngokukodwa kwizigulane ezine-NSCLC ezigcina utshintsho oluthile lwemfuza, njenge-EGFR, ALK, ROS1, okanye i-BRAF utshintsho. Imizekelo yeziyobisi zonyango ezijoliswe kuzo ziquka i-osimertinib (i-Tagrisso), i-crizotinib (i-Xalkori), kunye ne-afatinib (i-Gilotrif). Nangona unyango olujoliswe kuyo lunokukhokelela kwimiphumo engathandekiyo, efana nokuqhama kwesikhumba, isifo sohudo kunye neengxaki zesibindi. Uvavanyo lwemfuzo lubalulekile ukuchonga izigulane ezinokuxhamla kunyango ekujoliswe kulo.

Immunotherapy

I-Immunotherapy idibanisa amajoni omzimba ukulwa neeseli zomhlaza. Olu nyango lubaluleke kakhulu kunyango lwe umhlaza wemiphunga wemetastatic ongeyonxalenye encinci. I-immune checkpoint inhibitors, njenge-pembrolizumab (Keytruda) kunye ne-nivolumab (i-Opdivo), i-block proteins ekhusela amajoni omzimba ekuhlaseleni iiseli zomhlaza. Ngelixa unikezela ngeempendulo ezimangalisayo kwezinye izigulana, unyango lwe-immunotherapy lunokuba neziphumo ebezingalindelekanga, kubandakanya ukudinwa, irhashalala, kunye nokudumba. Ukufaneleka kwe-immunotherapy kuxhomekeke kwizinto ezifana ne-PD-L1 intetho kunye nomthwalo we-tumor mutational.

Unyango ngemitha

Unyango ngemitha isebenzisa imitha ephezulu yamandla ukubulala iiseli zomhlaza. Ingasetyenziselwa ukunyanga i-metastases yendawo okanye ukunciphisa iimpawu ezibangelwa ngumhlaza, njengentlungu okanye ubunzima bokuphefumla. Iindidi ezahlukeneyo zonyango lwemitha zikhona, kubandakanywa ukusasazeka kwemitha yangaphandle kunye nebrachytherapy. Iziphumo ebezingalindelekanga zonyango lwemitha zinokubandakanya ukucaphuka kwesikhumba, ukudinwa, kunye nesicaphucaphu.

UkuKhethwa koNyango kunye neMiba yesigulane

Ukukhetha isicwangciso sonyango esisiso umhlaza wemiphunga wemetastatic ongeyonxalenye encinci ifuna uphononongo olucokisekileyo lwezinto ezininzi. Oku kubandakanya impilo yesigulane iyonke, isimo sokusebenza, isigaba kunye neempawu zomhlaza, kunye nobukho balo naluphi na utshintsho oluthile lwemfuzo. Iqela leengcali ze-oncologists, i-radiologists, oogqirha botyando, kunye nezinye iingcali zempilo zihlala zisebenzisana ukuphuhlisa isicwangciso sonyango.

Iziko loPhando ngoMhlaza laseShandong Baofa (https://www.baofahospital.com/) uzinikele ekuboneleleni ngononophelo oluphezulu lomhlaza kunye nophando, kusetyenziswa itekhnoloji ye-cutting-edge kunye nendlela yokusebenzisana ukuhambisa iziphumo ezikhethekileyo zesigulane. Banikezela ngeenkonzo zokuxilonga kunye nonyango olubanzi kwiintlobo ezahlukeneyo zomhlaza, kubandakanywa umhlaza wemiphunga wemetastatic ongeyonxalenye encinci.

Uphando oluQhubekayo kunye nezikhokelo zexesha elizayo

Uphando luqhubela phambili ukuqonda kunye nonyango lwe umhlaza wemiphunga wemetastatic ongeyonxalenye encinci. Unyango olutsha olujoliswe kuyo, i-immunotherapies, kunye neendibaniselwano zalo zihlala ziphuhliswa kwaye zivavanywa kwizilingo zeklinikhi. Ezi nkqubela zinika ithemba kwiziphumo zonyango eziphuculweyo kunye nokuphucula umgangatho wobomi kwizigulana.

I-Disclaimer: Le ngcaciso yenzelwe iinjongo zemfundo kuphela kwaye akufanele ithathwe njengengcebiso yezonyango. Soloko udibana nomboneleli wakho wezempilo ukuze ufumane isikhokelo somntu malunga nemeko yakho ethile.